Equities

Adjuvant Holdings Co Ltd

4929:TYO

Adjuvant Holdings Co Ltd

Actions
Consumer DiscretionaryPersonal Goods
  • Price (JPY)850.00
  • Today's Change-2.00 / -0.23%
  • Shares traded4.60k
  • 1 Year change-7.91%
  • Beta0.3217
Data delayed at least 20 minutes, as of May 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd, is a Japan-based company mainly engaged in the planning, research, development and sale of adjuvant cosmetics, and the provision of related services. The Company is engaged in the provision of skin care products such as cleansings, facial cleanser, lotions, masks, moisturizing creams, makeup bases, makeup products and body care products, hair care products such as shampoos, treatments, scalp cleansers, scalp lotions, styling products and coloring products, as well as other products such as cloud-based management support systems and computer software related products. The Company is engaged in the provision of products to hairdressing salons, esthetic salons, nail salons, eyelash salons, beauty clinics and others.

  • Revenue in JPY (TTM)4.44bn
  • Net income in JPY-99.87m
  • Incorporated1990
  • Employees134.00
  • Location
    Adjuvant Holdings Co Ltd5-5-5, Shimoyamate-dori, Chuo-kuKOBE-SHI 650-0011JapanJPN
  • Phone+81 783513100
  • Fax+81 783513108
  • Websitehttps://www.adjuvant-hd.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Graphico Inc5.33bn262.31m3.56bn50.0014.021.4413.020.6682270.78270.785,558.622,633.141.403.434.85106,605,400.006.907.688.669.9336.4045.684.924.182.32--0.23880.0023.5412.5952.0557.17-16.33--
Azearth Corp8.39bn284.89m3.75bn163.0012.280.524910.310.447650.2650.261,479.061,175.410.95824.063.5051,465,020.003.254.464.125.8621.1320.463.403.782.96--0.03429.02-4.86-0.310652.7420.5020.8917.08
Soiken Holdings Inc5.34bn-618.91m4.29bn98.00--0.6787--0.8041-23.66-23.66203.95241.630.68152.506.8454,438,810.00-7.928.75-9.2710.9046.7746.98-11.627.338.97--0.0020.19-13.568.17-44.2017.941.6720.11
NANSIN CO., LTD.8.92bn155.81m4.34bn427.0024.100.32712.600.486823.3623.361,334.381,721.680.56061.934.69--0.97972.261.252.8324.2125.331.753.792.3028.070.143835.04-9.10-1.17-73.74-23.165.9714.87
ATOM LIVIN TECH Co., Ltd.10.28bn259.91m5.54bn126.0020.720.531712.490.539365.1665.162,576.222,539.070.776812.674.1181,559,780.001.963.442.534.3624.7327.422.534.152.56--0.0032.034.25-0.1299-15.84-4.94-18.801.92
C'BON COSMETICS Co Ltd8.50bn-26.35m6.02bn737.00--1.0657.280.7083-6.16-6.161,985.491,322.240.96322.2410.13---0.2986-4.32-0.4286-5.5475.3076.20-0.31-4.521.71--0.0008---0.3103-7.4993.75--15.74-17.81
Adjuvant Holdings Co Ltd4.44bn-99.87m6.85bn134.00--1.62269.691.54-12.50-12.50555.06527.070.81971.4210.62---1.842.25-2.082.5864.4563.70-2.252.684.26--0.0073141.261.39-2.98-124.74---30.17-12.94
Premier Antiaging Co Ltd22.79bn-2.39bn7.12bn252.00--1.20--0.3126-274.41-274.412,613.53679.211.872.1810.6090,440,270.00-19.6511.40-27.7420.0272.6878.45-10.503.822.02--0.27350.00-22.1539.62-151.53--78.15--
Shobido Corp21.03bn676.06m7.44bn232.0010.841.088.180.353951.1851.181,592.22511.631.357.585.7090,658,600.004.392.107.083.2126.0427.943.261.751.67--0.466552.9518.312.94-7.1137.80-3.8611.20
Iwabuchi Corp11.60bn401.67m7.96bn451.0019.340.427810.330.6865374.39374.3910,809.3816,924.840.48872.833.3625,723,200.001.712.782.013.2227.7227.713.505.653.90--0.054437.287.992.134.0221.67-12.390.00
Oizumi Corp21.39bn528.95m8.08bn421.0015.270.446.040.377623.5123.51951.00816.000.49952.704.99--1.242.411.623.0633.2730.972.476.031.5713.630.4925.3318.0117.08-65.06-2.43-16.075.92
Path Corp2.32bn-189.02m8.16bn56.00--6.90--3.53-3.66-3.6644.5721.021.671.9310.8941,354,640.00-13.65-24.68-17.29-40.5846.8749.95-8.16-16.651.80--0.00---5.79-10.2165.67--49.02--
HABA LABORATORIES, INC.12.32bn-2.12bn8.18bn654.00--0.9246--0.6641-560.26-560.263,259.062,249.650.911.1111.04---15.64-1.97-19.73-2.4568.1970.38-17.19-2.241.91-18.910.2168--2.38-8.54-199.30---1.730.00
Data as of May 20 2024. Currency figures normalised to Adjuvant Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

1.74%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Apr 202451.40k0.64%
Daiwa Asset Management Co. Ltd.as of 29 Mar 202430.50k0.38%
Nikko Asset Management Co., Ltd.as of 10 May 202424.90k0.31%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202410.80k0.13%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 20 Apr 20236.30k0.08%
BlackRock Japan Co. Ltd.as of 09 May 20245.70k0.07%
Nissay Asset Management Corp.as of 21 Feb 20235.00k0.06%
Asset Management One Co., Ltd.as of 09 May 20243.30k0.04%
Amundi Asset Management SA (Investment Management)as of 08 May 20241.33k0.02%
Resona Asset Management Co., Ltd.as of 11 Dec 2023500.000.01%
More ▼
Data from 11 Dec 2023 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.